주식회사메디플러스
주식회사메디플러스's KOBDi Score is 42.06 as of Sep 2026, up 0.41 points since Apr 2025; it rose in 4 of the 12 monthly updates and never fell. As of Sep 2026 it is ahead of about 69% of companies in its industry, against 69% in Aug 2026 and 72% in Apr 2025. Its strongest position was 73% (May 2025) and its weakest 68% (Jul 2026).
A year earlier, in Aug 2025, its score was 41.76 and it was ahead of about 68% of companies in its industry.
| Sep 2026 | 42.06 | ahead of 69% |
| Aug 2026 | 41.90 | ahead of 69% |
| Jul 2026 | 41.90 | ahead of 68% |
| Jun 2026 | 41.90 | ahead of 69% |
| May 2026 | 41.90 | ahead of 69% |
| Apr 2026 | 41.90 | ahead of 69% |
| Mar 2026 | 41.82 | ahead of 68% |
| Feb 2026 | 41.76 | ahead of 69% |
| Dec 2025 | 41.76 | ahead of 68% |
| Aug 2025 | 41.76 | ahead of 68% |
| Jul 2025 | 41.65 | ahead of 72% |
| May 2025 | 41.65 | ahead of 73% |
| Apr 2025 | 41.65 | ahead of 72% |
Where is 주식회사메디플러스 located?
주식회사메디플러스 is registered at 충청북도 청주시 흥덕구 2순환로, South Korea (postal code 28396).
What industry is 주식회사메디플러스 in?
주식회사메디플러스 belongs to Manufacturing › Other Medical & Precision Devices › Other medical device manufacturing.
How many employees does 주식회사메디플러스 have?
주식회사메디플러스 has 1–4 employees.
What is 주식회사메디플러스's KOBDi Score?
42.06 as of September 2026, ahead of about 69% of companies in its industry.
Who are 주식회사메디플러스's competitors?
Similar companies include Seongbo, 주식회사세손메디컬 and Olmed.


